Keyphrases
Performance Evaluation
100%
Cerebrospinal Fluid
100%
Laboratory Experiences
100%
Evaluation Experiences
100%
Anti-NMDAR Encephalitis
100%
IgG Assay
100%
Anti-NMDA Receptor
100%
Anti-NMDAR
80%
Antibody Titer
40%
Clinical Information
20%
Treatment Outcome
20%
N-methyl-D-aspartate Receptor (NMDAR)
20%
Disease Control
20%
Pediatric Population
20%
Disease Severity
20%
Novel Form
20%
Antibody Targeting
20%
Response to Treatment
20%
High Prevalence
20%
Diagnostic Performance
20%
Variable Response
20%
Positivity Rate
20%
Titer
20%
Germany
20%
As(V)
20%
Disease Groups
20%
IgG Antibody
20%
N-methylation
20%
Performance Characteristics
20%
Male-to-female Ratio
20%
Excellent Performance
20%
Indirect Immunofluorescence Assay
20%
Positive Samples
20%
NR1 Subunit
20%
Autoimmune Encephalitis
20%
D-aspartate
20%
Euroimmun
20%
Immunology and Microbiology
Cerebrospinal Fluid
100%
Encephalitis
100%
N Methyl Dextro Aspartic Acid Receptor Antibody
100%
Prevalence
40%
Antibody Titer
40%
Autoimmune Encephalitis
20%
Titer
20%
Dilution
20%
Immunoglobulin G
20%
Immunofluorescence
20%